Both in Biotechnology
PharmaCyte Biotech vs Curis
Over the past year PMCB returned −65.3% and CRIS returned −98.7%; their daily moves had a correlation of -0.02.
PMCB −65.3% CRIS −98.7%Growth of $1, one year, split-adjusted
| Metric | PMCB | CRIS |
|---|---|---|
| Price | $0.3402 | $0.4071 |
| Market cap | $3.7M | $987.2K |
| Today | −4.81% | −19.86% |
| 1 month | −19.8% | −62.7% |
| 6 months | −53.3% | −96.6% |
| Year to date | −53.0% | −97.9% |
| 1 year | −66.3% | −98.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $30.5M | $5.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.6% | 129.6% |
| Short % of float | 1.4% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).